Phase I-II trial of a monoclonal anti-tumor necrosis factor α antibody for the treatment of refractory severe acute graft-versus-host disease

Blood

Volumn 79, Issue 12, 1992, Pages 3362-3368

  Herve, P ^a   Flesch, M ^a   Tiberghien, P ^a   Wijdenes, J ^a   Racadot, E ^a   Bordigoni, P ^a   Plouvier, E ^a   Stephan, J L ^a   Bourdeau, H ^a   Holler, E ^a   Lioure, B ^a   Roche, C ^a   Vilmer, E ^a   Demeocq, F ^a   Kuentz, M ^a   Cahn, J Y ^a  

^a Etablissement de Transfus Sanguine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; METHOTREXATE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B C7; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BIOPSY; BLOOD CELL COUNT; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; DRUG INFUSION; DRUG TOLERANCE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HLA SYSTEM; HUMAN; INFANT; INTESTINE; LIVER; MALE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; SKIN;

EID: 0026754027     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v79.12.3362.3362     Document Type: Article

References (0)